[go: up one dir, main page]

DK116689A - Pyrroloquinolin- og pyrrolophenothiazin-carboxamider og beslaegtede forbindelser samt farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af laegemidler til behandling af inflammation eller andre prostaglandin- eller leukotrin-formidlede sygdomme - Google Patents

Pyrroloquinolin- og pyrrolophenothiazin-carboxamider og beslaegtede forbindelser samt farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af laegemidler til behandling af inflammation eller andre prostaglandin- eller leukotrin-formidlede sygdomme

Info

Publication number
DK116689A
DK116689A DK116689A DK116689A DK116689A DK 116689 A DK116689 A DK 116689A DK 116689 A DK116689 A DK 116689A DK 116689 A DK116689 A DK 116689A DK 116689 A DK116689 A DK 116689A
Authority
DK
Denmark
Prior art keywords
treatment
pyrrolophenothiazine
pyrroloquinolin
carboxamides
preparation
Prior art date
Application number
DK116689A
Other languages
English (en)
Other versions
DK116689D0 (da
DK169723B1 (da
Inventor
Banavara Lakshmana Mylari
Joseph George Lombardino
James Michael Mcmanus
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK116689D0 publication Critical patent/DK116689D0/da
Publication of DK116689A publication Critical patent/DK116689A/da
Application granted granted Critical
Publication of DK169723B1 publication Critical patent/DK169723B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK116689A 1988-03-11 1989-03-10 Pyrroloquinolin- og pyrrolophenothiazin-carboxamider og beslægtede forbindelser samt farmaceutiske præparater indeholdende disse og deres anvendelse til fremstilling af lægemidler til behandling af inflammation eller andre prostaglandin- eller leukotrin-formidlede sygdomme DK169723B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1988/000781 WO1989008654A1 (en) 1988-03-11 1988-03-11 Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
US8800781 1988-03-11

Publications (3)

Publication Number Publication Date
DK116689D0 DK116689D0 (da) 1989-03-10
DK116689A true DK116689A (da) 1989-09-12
DK169723B1 DK169723B1 (da) 1995-01-23

Family

ID=22208596

Family Applications (1)

Application Number Title Priority Date Filing Date
DK116689A DK169723B1 (da) 1988-03-11 1989-03-10 Pyrroloquinolin- og pyrrolophenothiazin-carboxamider og beslægtede forbindelser samt farmaceutiske præparater indeholdende disse og deres anvendelse til fremstilling af lægemidler til behandling af inflammation eller andre prostaglandin- eller leukotrin-formidlede sygdomme

Country Status (15)

Country Link
EP (1) EP0332364A3 (da)
JP (1) JPH0676408B2 (da)
KR (1) KR910002565B1 (da)
AU (1) AU605410B2 (da)
CA (1) CA1335592C (da)
DK (1) DK169723B1 (da)
FI (1) FI96315C (da)
HU (1) HU201757B (da)
IL (1) IL89480A (da)
MY (1) MY104955A (da)
NO (1) NO170418C (da)
NZ (1) NZ228299A (da)
PT (1) PT89954B (da)
WO (1) WO1989008654A1 (da)
ZA (1) ZA891800B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
JPH06279444A (ja) * 1993-03-31 1994-10-04 Tokyo Tanabe Co Ltd インドリジン誘導体
US6084098A (en) 1999-02-26 2000-07-04 Neurogen Corporation Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
CA2321830A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
CN101014345A (zh) * 2004-09-09 2007-08-08 默克公司 三环酰苯胺螺环内酰胺cgrp受体拮抗剂
US7750010B2 (en) * 2004-09-13 2010-07-06 Merck Sharp & Dohme Corp. Tricyclic anilide spirohydantion CGRP receptor antagonists
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
CN108853102B (zh) * 2017-05-15 2021-04-09 北京大学 作用于Dectin-1的稠合吖啶衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1394373A (en) * 1972-05-17 1975-05-14 Pfizer Ltd Control of plant diseases
EP0139584B1 (fr) * 1983-10-17 1988-05-18 Synthelabo Dérivés d'imidazoline, leur préparation et leur application en thérapeutique
FR2567126B1 (fr) * 1984-07-06 1986-12-12 Synthelabo Derives de pyrrolo(1,2,3-de) benzoxazine et benzothiazine, leur preparation et leur application en therapeutique
JPS6317885A (ja) * 1986-07-11 1988-01-25 Kyorin Pharmaceut Co Ltd スピロピロリジン−２，５−ジオン誘導体の製造方法

Also Published As

Publication number Publication date
NO170418B (no) 1992-07-06
HU885829D0 (en) 1990-02-28
PT89954A (pt) 1989-11-10
JPH01275580A (ja) 1989-11-06
NO894350D0 (no) 1989-11-01
KR890014545A (ko) 1989-10-24
NO894350L (no) 1989-11-01
AU605410B2 (en) 1991-01-10
JPH0676408B2 (ja) 1994-09-28
AU3120489A (en) 1989-09-14
DK116689D0 (da) 1989-03-10
EP0332364A3 (en) 1991-04-03
FI96315C (fi) 1996-06-10
ZA891800B (en) 1990-10-31
PT89954B (pt) 1994-05-31
WO1989008654A1 (en) 1989-09-21
NO170418C (no) 1992-10-14
FI96315B (fi) 1996-02-29
IL89480A0 (en) 1989-09-10
NZ228299A (en) 1990-09-26
MY104955A (en) 1994-07-30
CA1335592C (en) 1995-05-16
IL89480A (en) 1994-04-12
EP0332364A2 (en) 1989-09-13
KR910002565B1 (ko) 1991-04-26
DK169723B1 (da) 1995-01-23
HU201757B (en) 1990-12-28
FI895333A0 (fi) 1989-11-09

Similar Documents

Publication Publication Date Title
DK161709C (da) 13-alkyl-11beta-phenylgonaner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem samt deres anvendelse til fremstilling af laegemidler
DK674389D0 (da) Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af artritiske og inflammatoriske sygdomme
FI941979L (fi) Farmaseuttiset tuotteet kasvainsairausten hoitamiseksi ja menetelmä niiden valmistamiseksi
DK272389D0 (da) Anvendelse af gamma-hydroxysmoersyresalte til fremstilling af farmaceutiske praeparater til behandling af alkoholisme og praeparater opnaaet herved
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
DK51493D0 (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
DK184890D0 (da) Anvendelse af anti-t-celle-immunotoxin til fremstilling af farmaceutiske praeparater til behandling af autoimmune sygdomme
FI951614L (fi) D-vitamiinisarjan 25-karboksyylihappojohdannaisia, menetelmät niiden valmistamiseksi, näissä menetelmissä käytettävät välituotteet, näitä johdansia sisältävät farmaseuttiset valmisteet ja näiden johdannaisten käyttö lääkeaineiden valmistukseen
DK279890A (da) Liposom-indkapslede vincaalkaloider og anvendelse heraf til fremstilling af et laegemiddel til bekaempelse af tumorer
DK610988A (da) Polypeptider, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater der indeholder dem samt anvendelse deraf til fremstilling af et laegemiddel
DK394489D0 (da) Benzamid- og sulfonbenzamid-forbindelser, deres anvendelse til fremstilling af antiarytmiske laegemidler, farmaceutiske praeparater indeholdende forbindelserne og mellemprodukter ved fremstilling af forbindelserne
NO872551D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
PT87243A (pt) Process for the preparation of aliphatic carboxamides and of pharmaceutical compounds containing them
DK116689A (da) Pyrroloquinolin- og pyrrolophenothiazin-carboxamider og beslaegtede forbindelser samt farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af laegemidler til behandling af inflammation eller andre prostaglandin- eller leukotrin-formidlede sygdomme
FI920425A7 (fi) Sykloalkyleeniatsoleja, menetelmä niiden valmistamiseksi niitä sisältä viä farmaseuttisia valmisteita sekä niiden käyttö lääkeaineiden valmis tamiseen
NO874200L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO873423D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO875359D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO872233D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK463189D0 (da) 1,4-dihydropyridin-derivater, farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af antiallergiske og antiinflammatoriske laegemidler
DK369088D0 (da) Fremgangsmaade til fremstilling af nukleinsyrederivater og fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende disse
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK9086D0 (da) Naphthalenderivater af benzonorbornen, fremgangsmaade til deres fremstilling og laegemidler og kosmetikpraeparater indeholdende saadanne forbindelser
DK328087D0 (da) N-imidazolylmethyl-diphenylazomethiner samt fremgangsmaade til fremstilling af saadanne forbindelser og anvendelse af disse i farmaceutiske praeparater
NO893291D0 (no) Fremgangsmaate for fremstilling av nye benzasolderivater og farmasoeytiske preparater derav.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed